In the STEP 1 extension, participants regained about two-thirds of their previous loss during the following year
The healing phase requires specific care that may not include copper peptides
Clinical trials supporting tirzepatide's approval used a strict weekly schedule at fixed doses (0.5 mg, 1 mg, 2.5 mg, 5 mg, 10 mg, or 15 mg)
In February 2025, Gan & Lee Pharmaceuticals (hereafter referred to as "Gan & Lee," stock code: 603087.SH) unveiled that the first participant was successfully dosed in a large-scale Phase 3 clinical trial (OPTIMUM-2) of Bofanglutide, a bi-weekly glucagon-like peptide-1 receptor agonist (GLP-1RA) independently, in Chinese participant with type 2 diabetes mellitus (T2DM)
It increases growth hormone secretion and IGF-1 production, both of which support muscle protein synthesis
There are several tips and tricks you can implement to assist with an effective and safe use of the medication